These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 38527174)
1. Role of Interleukin 1 Receptor 2 in Kidney Disease. Hu H; Wu A; Mu X; Zhou H J Interferon Cytokine Res; 2024 Apr; 44(4):170-177. PubMed ID: 38527174 [TBL] [Abstract][Full Text] [Related]
2. Regulation of IL-1 signaling by the decoy receptor IL-1R2. Schlüter T; Schelmbauer C; Karram K; Mufazalov IA J Mol Med (Berl); 2018 Oct; 96(10):983-992. PubMed ID: 30109367 [TBL] [Abstract][Full Text] [Related]
3. Negative regulator IL-1 receptor 2 (IL-1R2) and its roles in immune regulation of autoimmune diseases. Zhang Y; Liu K; Guo M; Yang Y; Zhang H Int Immunopharmacol; 2024 Jul; 136():112400. PubMed ID: 38850793 [TBL] [Abstract][Full Text] [Related]
4. Negative Regulation of the IL-1 System by IL-1R2 and IL-1R8: Relevance in Pathophysiology and Disease. Supino D; Minute L; Mariancini A; Riva F; Magrini E; Garlanda C Front Immunol; 2022; 13():804641. PubMed ID: 35211118 [TBL] [Abstract][Full Text] [Related]
5. Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8. Molgora M; Supino D; Mantovani A; Garlanda C Immunol Rev; 2018 Jan; 281(1):233-247. PubMed ID: 29247989 [TBL] [Abstract][Full Text] [Related]
6. ADAM17 regulates IL-1 signaling by selectively releasing IL-1 receptor type 2 from the cell surface. Uchikawa S; Yoda M; Tohmonda T; Kanaji A; Matsumoto M; Toyama Y; Horiuchi K Cytokine; 2015 Feb; 71(2):238-45. PubMed ID: 25461404 [TBL] [Abstract][Full Text] [Related]
7. Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma. Oelmann E; Stein H; Berdel WE; Herbst H PLoS One; 2015; 10(9):e0138747. PubMed ID: 26406983 [TBL] [Abstract][Full Text] [Related]
8. Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions. Martin P; Palmer G; Vigne S; Lamacchia C; Rodriguez E; Talabot-Ayer D; Rose-John S; Chalaris A; Gabay C J Leukoc Biol; 2013 Oct; 94(4):791-802. PubMed ID: 23817563 [TBL] [Abstract][Full Text] [Related]
9. Regulated intramembrane proteolysis of the interleukin-1 receptor II by alpha-, beta-, and gamma-secretase. Kuhn PH; Marjaux E; Imhof A; De Strooper B; Haass C; Lichtenthaler SF J Biol Chem; 2007 Apr; 282(16):11982-95. PubMed ID: 17307738 [TBL] [Abstract][Full Text] [Related]
10. Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation. Rauschmayr T; Groves RW; Kupper TS Proc Natl Acad Sci U S A; 1997 May; 94(11):5814-9. PubMed ID: 9159157 [TBL] [Abstract][Full Text] [Related]
11. Molecular and functional characterization of chicken interleukin 1 receptor 2 (chIL-1R2). Truong AD; Tran HTT; Nguyen HT; Chu NT; Hong YH; Lillehoj HS; Dang HV; Song KD Poult Sci; 2023 Feb; 102(2):102399. PubMed ID: 36586293 [TBL] [Abstract][Full Text] [Related]
12. Type II interleukin-1 receptor expression is reduced in monocytes/macrophages and atherosclerotic lesions. Pou J; Martínez-González J; Rebollo A; Rodríguez C; Rodríguez-Calvo R; Martín-Fuentes P; Cenarro A; Civeira F; Laguna JC; Alegret M Biochim Biophys Acta; 2011 Sep; 1811(9):556-63. PubMed ID: 21683158 [TBL] [Abstract][Full Text] [Related]
13. IL-1 receptor 2 (IL-1R2) and its role in immune regulation. Peters VA; Joesting JJ; Freund GG Brain Behav Immun; 2013 Aug; 32():1-8. PubMed ID: 23195532 [TBL] [Abstract][Full Text] [Related]
14. Molecular and functional characterization of IL-1 receptor type 2 in grass carp: a potent inhibitor of IL-1β signaling in head kidney leukocytes. Yang X; Wang S; Du L; Yang K; Wang X; Zhang A; Zhou H Dev Comp Immunol; 2013 Dec; 41(4):738-45. PubMed ID: 23999049 [TBL] [Abstract][Full Text] [Related]
15. Gene transfer of a soluble IL-1 type 2 receptor-Ig fusion protein improves cardiac allograft survival in rats. Simeoni E; Dudler J; Fleury S; Li J; Pagnotta M; Pascual M; von Segesser LK; Vassalli G Eur J Cardiothorac Surg; 2007 Feb; 31(2):222-8. PubMed ID: 17182252 [TBL] [Abstract][Full Text] [Related]
16. Negative regulatory receptors of the IL-1 family. Garlanda C; Riva F; Bonavita E; Mantovani A Semin Immunol; 2013 Dec; 25(6):408-15. PubMed ID: 24239046 [TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor tyrosine kinase inhibitors induce CCL2 and CCL5 via reduction in IL-1R2 in keratinocytes. Yamaki M; Sugiura K; Muro Y; Shimoyama Y; Tomita Y Exp Dermatol; 2010 Aug; 19(8):730-5. PubMed ID: 20590818 [TBL] [Abstract][Full Text] [Related]
18. Cardiomyocyte IL-1R2 protects heart from ischemia/reperfusion injury by attenuating IL-17RA-mediated cardiomyocyte apoptosis. Lin J; Li Q; Jin T; Wang J; Gong Y; Lv Q; Wang M; Chen J; Shang M; Zhao Y; Fu G Cell Death Dis; 2022 Jan; 13(1):90. PubMed ID: 35087030 [TBL] [Abstract][Full Text] [Related]
19. Epithelial IL-1R2 acts as a homeostatic regulator during remission of ulcerative colitis. Mora-Buch R; Dotti I; Planell N; Calderón-Gómez E; Jung P; Masamunt MC; Llach J; Ricart E; Batlle E; Panés J; Salas A Mucosal Immunol; 2016 Jul; 9(4):950-9. PubMed ID: 26530134 [TBL] [Abstract][Full Text] [Related]
20. IL-1 receptor type 2 suppresses collagen-induced arthritis by inhibiting IL-1 signal on macrophages. Shimizu K; Nakajima A; Sudo K; Liu Y; Mizoroki A; Ikarashi T; Horai R; Kakuta S; Watanabe T; Iwakura Y J Immunol; 2015 Apr; 194(7):3156-68. PubMed ID: 25725107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]